Itau Unibanco Holding S.A.’s Caribou Biosciences CRBU Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-96	Closed	-$581	–	525
2022 Q4	$581	Buy	+96	New	+$854	﹤0.01%	505
2022 Q3	–	Sell	-99	Closed	-$1K	–	562
2022 Q2	$1K	Buy	+99	New	+$757	﹤0.01%	453

Other funds holding CRBU

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Itau Unibanco Holding S.A.'s CRBU Position: Q1 2023 in Review

Itau Unibanco Holding S.A. sold out of Caribou Biosciences (CRBU) in Q1 2023, closing a stake of 96 shares — an estimated $581 sold.

Itau Unibanco Holding S.A. first reported a position in CRBU in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 126 funds tracked by Wall St. Rank hold CRBU as of Q1 2023.

Itau Unibanco Holding S.A. reported no remaining Caribou Biosciences position as of Q1 2023 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 96 Caribou Biosciences shares in Q1 2023, an estimated $581.
Itau Unibanco Holding S.A. first reported a position in Caribou Biosciences in Q2 2022 and held it in 2 quarters.
Itau Unibanco Holding S.A.'s Caribou Biosciences position peaked at $1K in Q2 2022.
126 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2023, filed 12 May 2023.